Understanding NCKIPSD: Potential Drug Target and Biomarker for Neurodegenerative Diseases

Target Name: NCKIPSD

NCBI ID: G51517

NCKIPSD

Understanding NCKIPSD: Potential Drug Target and Biomarker for Neurodegenerative Diseases

NCKIPSD (Wiskott-Aldrich Syndrome Protein-Interacting Protein) is a protein that is expressed in various tissues throughout the body, including the nervous system, and is involved in the development and maintenance of neuronal function. It has also been implicated in the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

Recent studies have identified NCKIPSD as a potential drug target or biomarker for several reasons. Firstly,NCKIPSD has been shown to play a role in the development of neurodegenerative diseases, which makes it an attractive target for drug development. Secondly, the protein is expressed in various tissues and is highly conserved across species, which suggests that it may be a useful biomarker for tracking disease progression. Thirdly, NCKIPSD has been shown to interact with a wide range of proteins, including known drug targets, which suggests that it may be a useful protein for targeting new treatments.

One of the key challenges in studying NCKIPSD is its complex structure and function. The protein is composed of several hundred amino acids and has a predicted molecular weight of approximately 18 kDa. It is expressed in various tissues, including the brain, and is involved in the development and maintenance of neuronal function. However, much of its function and structure are still not well understood.

One of the key functions of NCKIPSD is its role in the development and progression of neurodegenerative diseases. Studies have shown that NCKIPSD is involved in the development of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In addition, NCKIPSD has been shown to contribute to the pathophysiology of these diseases by promoting neurotoxicity and oxidative stress.

Another function of NCKIPSD is its potential as a drug target. Its interaction with known drug targets, such as heat shock protein (HSP)70 and microtubule-associated protein (MAP), makes it an attractive target for new treatments. Additionally, its role in the development and progression of neurodegenerative diseases makes it an important protein to target for the development of new therapies for these diseases.

In conclusion, NCKIPSD is a protein that is expressed in various tissues throughout the body and is involved in the development and maintenance of neuronal function. Its complex structure and function make it an attractive target for drug development, and its involvement in the development and progression of neurodegenerative diseases makes it an important protein to target for the development of new therapies. Further research is needed to fully understand the role of NCKIPSD in the development and progression of neurodegenerative diseases, as well as its potential as a drug target.

Protein Name: NCK Interacting Protein With SH3 Domain

Functions: Has an important role in stress fiber formation induced by active diaphanous protein homolog 1 (DRF1). Induces microspike formation, in vivo (By similarity). In vitro, stimulates N-WASP-induced ARP2/3 complex activation in the absence of CDC42 (By similarity). May play an important role in the maintenance of sarcomeres and/or in the assembly of myofibrils into sarcomeres. Implicated in regulation of actin polymerization and cell adhesion. Plays a role in angiogenesis

The "NCKIPSD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCKIPSD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets